Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Más filtros











Intervalo de año de publicación
1.
Arch. Soc. Esp. Oftalmol ; 98(6): 351-354, jun. 2023. ilus
Artículo en Español | IBECS | ID: ibc-221227

RESUMEN

Se presenta el caso de una mujer de 79 años con glaucoma severo y falta de adherencia al tratamiento, que es sometida a cirugía de catarata e implante XEN® en su ojo izquierdo. Dos semanas después de la intervención se objetiva una erosión conjuntival con exposición del extremo distal del implante, por lo que se realiza una reparación quirúrgica mediante la combinación de una sutura aposicional del tubo, adaptando su trayectoria a la curvatura escleral, y el recubrimiento con injerto de membrana amniótica. Tras 6 meses de seguimiento, presenta una presión intraocular controlada, sin necesidad de tratamiento adicional, y sin mostrar progresión de su enfermedad (AU)


We report a case of a 79-year-old woman with severe glaucoma and absence of therapeutic adherence, who underwent cataract surgery and XEN® implant in her left eye. Two weeks after the intervention, conjunctival erosion was observed with exposure of the distal end of the implant, so a surgical repair was performed by combining an appositional suture of the tube, adapting its trajectory to the scleral curvature, and an amniotic membrane graft. After 6 months of follow-up, the intraocular pressure was controlled, without additional treatment needed, and no disease progression (AU)


Asunto(s)
Humanos , Femenino , Anciano , Glaucoma/cirugía , Lentes Intraoculares , Índice de Severidad de la Enfermedad , Tomografía de Coherencia Óptica
2.
Arch Soc Esp Oftalmol (Engl Ed) ; 98(6): 351-354, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-37120075

RESUMEN

We report a case of a 79-year-old woman with severe glaucoma and absence of therapeutic adherence, who undergone cataract surgery and XEN® implant in her left eye. Two weeks after the intervention, conjunctival erosion was observed with exposure of the distal end of the implant, so a surgical repair was performed by combining an appositional suture of the tube, adapting its trajectory to the scleral curvature, and an amniotic membrane graft. After 6 months of follow-up, the intraocular pressure is controlled, without additional treatment needed, and no disease progression.


Asunto(s)
Implantes de Drenaje de Glaucoma , Humanos , Femenino , Anciano , Amnios , Stents , Presión Intraocular , Tonometría Ocular
3.
Arch Soc Esp Oftalmol (Engl Ed) ; 95(10): 485-495, 2020 Oct.
Artículo en Inglés, Español | MEDLINE | ID: mdl-32600835

RESUMEN

BACKGROUND AND PURPOSE: Although taxanes are a frequently used group of chemotherapy agents, they can, rarely, lead to macular oedema. The purpose of this article is to review and communicate, in an integrated way, the data of the cases previously reported in the literature, as well as to present a new case. MATERIAL AND METHODS: Narrative review of reports of cases of macular oedema associated with taxanes, and communication of the clinical case of a 73-year-old woman who, after treatment with paclitaxel for metastatic breast cancer, developed macular oedema that disappeared after discontinuing the drug. RESULTS: The review included 57 cases with data from 109 eyes collected in 52 articles. The large majority (76.79%) of the cases were women, and the mean age was 58.75 years. The cancer that most frequently motivated the treatment was breast cancer (60.72%), and 92.5% of cases had metastases. The most frequently associated drug was paclitaxel (52.63%). The median time to symptom development was 4.25 months. At the initial examination, 92.86% of the cases had bilateral oedema and the mean visual acuity was 0.4 (decimal scale). The mean macular thickness was 509.63 microns, and 97.83% of the eyes had no or minimal angiographic findings. In 90.57% of the cases, the treatment with taxanes was interrupted, and some other treatment was used in 43.86% of the cases, with the most widely used being acetazolamide. The outcome was favourable, to a greater or lesser extent, in 96.23% of cases. CONCLUSIONS: Despite being a rare entity, macular oedema associated with the use of taxanes is a disorder that every oncologist and ophthalmologist should be aware of, taking into account the good outcome of the condition that usually occurs when treatment is suspended.

13.
Arch Soc Esp Oftalmol ; 80(7): 421-4, 2005 Jul.
Artículo en Español | MEDLINE | ID: mdl-16059820

RESUMEN

CASE REPORT: We describe the case of a 36-year-old man with a history of intravenous heroin use, who was HIV negative. Left ocular examination disclosed a focal candida retinitis in the posterior pole associated with vitritis and moderate iritis. Treatment with fluconazole inactived the chorio-retinal lesion and resolved the vitritis, but developed an inner limiting membrane contraction over the macula. Two years later, vitreous traction produced a retinal hole that needed argon laser photocoagulation. DISCUSSION: Candida retinitis which penetrates into the vitreous cavity can produce retinal holes by vitreous traction over the lesion.


Asunto(s)
Candidiasis/complicaciones , Infecciones Fúngicas del Ojo/complicaciones , Perforaciones de la Retina/etiología , Retinitis/microbiología , Adulto , Antifúngicos/uso terapéutico , Candidiasis/diagnóstico , Candidiasis/tratamiento farmacológico , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Infecciones Fúngicas del Ojo/microbiología , Fluconazol/uso terapéutico , Humanos , Coagulación con Láser , Masculino , Perforaciones de la Retina/cirugía , Retinitis/tratamiento farmacológico , Resultado del Tratamiento , Agudeza Visual
16.
Arch Soc Esp Oftalmol ; 79(6): 281-8, 2004 Jun.
Artículo en Español | MEDLINE | ID: mdl-15221674

RESUMEN

PURPOSE: To determine, by means of immunohistochemistry, tumoral expression of collagenase-3, a matrix metalloproteinase linked to cancer and to basal cell and squamous cell carcinomas of the eyelid. MATERIAL AND METHOD: Retrospective review of 23 basal cell carcinomas and 25 squamous cell carcinomas of the eyelid treated at different hospitals during the last five years. We evaluated collagenase-3 expression and the possible relationship to patient and tumour characteristics which included age, sex, histological type, tumour location and surgical margins status. RESULTS: 65% of the basal cell carcinomas and 88% of the squamous cell carcinomas of the eyelids stained positively for collagenase-3. In both cases, the immunostaining was localized in the cytoplasm of the malignant cells and, occasionally in the surrounding stromal cells. CONCLUSIONS: Statistical analysis showed no significant association between collagenase-3 immunostaining and patients or tumour characteristics but the expression of this protein was more intense in the epithelial tumoral cells located at the invading front which could explain the aggressive behaviour of this kind of tumours.


Asunto(s)
Carcinoma Basocelular/enzimología , Carcinoma de Células Escamosas/enzimología , Colagenasas/biosíntesis , Neoplasias de los Párpados/enzimología , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Basocelular/patología , Carcinoma de Células Escamosas/patología , Neoplasias de los Párpados/patología , Femenino , Humanos , Masculino , Metaloproteinasa 13 de la Matriz , Persona de Mediana Edad , Estudios Retrospectivos
17.
Arch Soc Esp Oftalmol ; 79(4): 177-80, 2004 Apr.
Artículo en Español | MEDLINE | ID: mdl-15124074

RESUMEN

CASE REPORT: A young female patient with systemic lupus erithematosus, inactive for a long period, is described. She develops bilateral serous detachments of the retinal pigment epithelium and neurosensory retina after corticosteroid therapy for a residual nephritis. DISCUSSION: This unusual chorioretinopathy has been reported in association with systemic lupus erithematosus and during corticosteroid therapy in many disorders. This patient, with low activity erithematosus lupus, develops serous retinal detachments after receiving corticosteroid therapy that damage the coriocapillary-pigment epithelium barrier, disordered in lupus patients.


Asunto(s)
Glucocorticoides/efectos adversos , Lupus Eritematoso Sistémico/tratamiento farmacológico , Prednisona/efectos adversos , Desprendimiento de Retina/inducido químicamente , Adulto , Femenino , Angiografía con Fluoresceína , Fondo de Ojo , Glucocorticoides/administración & dosificación , Humanos , Prednisona/administración & dosificación , Desprendimiento de Retina/cirugía , Resultado del Tratamiento , Agudeza Visual
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA